Journal:Acta Cryst F:S2053230X20016015
From Proteopedia
(Difference between revisions)
| Line 6: | Line 6: | ||
We were unable to express the wild-type kinase domain (1-346) of hematopoietic progenitor kinase 1 (HPK1, also called MAP4K1). We investigated the potential surface aggregation properties of a model of HPK1 and chose eight sites to investigate by yeast surface display. This led to a double mutant L221D F225E, which expressed in baculovirus-infected insect cells at multiple milligrams per liter of culture. Purification of this construct showed that it was truncated after residue 319, which led to a revised construct of HPK1(1-319) L221D F225E. This construct crystallized in the presence of inhibitors and led to a structure with two molecules/asymmetric unit. The activation loop on both molecules was domain-swapped, that is the activation loop of chain A bind to chain B and vice versa. We were able to use this construct to determine many structures of HPK1/inhibitor complexes in support a structure-based drug design effort. | We were unable to express the wild-type kinase domain (1-346) of hematopoietic progenitor kinase 1 (HPK1, also called MAP4K1). We investigated the potential surface aggregation properties of a model of HPK1 and chose eight sites to investigate by yeast surface display. This led to a double mutant L221D F225E, which expressed in baculovirus-infected insect cells at multiple milligrams per liter of culture. Purification of this construct showed that it was truncated after residue 319, which led to a revised construct of HPK1(1-319) L221D F225E. This construct crystallized in the presence of inhibitors and led to a structure with two molecules/asymmetric unit. The activation loop on both molecules was domain-swapped, that is the activation loop of chain A bind to chain B and vice versa. We were able to use this construct to determine many structures of HPK1/inhibitor complexes in support a structure-based drug design effort. | ||
| - | <scene name='87/870564/Cv/4'>The contents of the asymmetric unit</scene> are shown with chain A in cyan and chain B in violet. | + | <scene name='87/870564/Cv/4'>The contents of the asymmetric unit</scene> are shown with chain A in cyan and chain B in violet. Between the two monomers one can see the domain swapping of the activation loop. |
| - | + | ||
<b>References</b><br> | <b>References</b><br> | ||
<references/> | <references/> | ||
</StructureSection> | </StructureSection> | ||
__NOEDITSECTION__ | __NOEDITSECTION__ | ||
Revision as of 13:48, 22 December 2020
| |||||||||||
This page complements a publication in scientific journals and is one of the Proteopedia's Interactive 3D Complement pages. For aditional details please see I3DC.
